UBS Maintains Neutral on Xometry, Raises Price Target to $95
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joshua Chan maintains Xometry (NASDAQ:XMTR) with a Neutral and raises the price target from $88 to $95.
UBS analyst Joshua Chan maintains Xometry (NASDAQ:XMTR) with a Neutral and raises the price target from $88 to $95.